Gunnar M. Páh
Director/Miembro de la Junta en Corflow Therapeutics AG .
Cargos activos de Gunnar M. Páh
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Corflow Therapeutics AG
Corflow Therapeutics AG Medical SpecialtiesHealth Technology Corflow Therapeutics AG is a company based in Switzerland that is developing proprietary technologies to measure the coronary microvascular status and provide therapy to the compromised coronary microcirculation at the same time in the catheter laboratory. The Swiss company's focus is on treating microvascular obstruction (MVO) after an acute heart attack, which is documented to be an independent marker leading to costly complications such as heart failure. Corflow's technologies may enable interventional cardiologists to treat MVO in severe heart attack patients, thereby potentially reducing the short- and long-term complication rates in these patients. The company was founded in 2016 by Martin T. Rothman and Robert S. Schwartz. | Director/Miembro de la Junta | - | - |
Historial de carrera de Gunnar M. Páh
Estadísticas
Internacional
Suiza | 2 |
Operativa
Director/Board Member | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Corflow Therapeutics AG
Corflow Therapeutics AG Medical SpecialtiesHealth Technology Corflow Therapeutics AG is a company based in Switzerland that is developing proprietary technologies to measure the coronary microvascular status and provide therapy to the compromised coronary microcirculation at the same time in the catheter laboratory. The Swiss company's focus is on treating microvascular obstruction (MVO) after an acute heart attack, which is documented to be an independent marker leading to costly complications such as heart failure. Corflow's technologies may enable interventional cardiologists to treat MVO in severe heart attack patients, thereby potentially reducing the short- and long-term complication rates in these patients. The company was founded in 2016 by Martin T. Rothman and Robert S. Schwartz. | Health Technology |
- Bolsa de valores
- Insiders
- Gunnar M. Páh
- Experiencia